NPI: 1679820534 · LIMA, OH 45801 · Clinical Medical Laboratory · NPI assigned 08/10/2012
Authorized official RALSTON, KIMBERLY controls 20+ related entities in our dataset. Read more
| Authorized Official | RALSTON, KIMBERLY (VP REIMBURSEMENT) |
| NPI Enumeration Date | 08/10/2012 |
Other providers sharing the same authorized official: RALSTON, KIMBERLY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 5,249 | $36K |
| 2019 | 17,254 | $151K |
| 2020 | 24,604 | $238K |
| 2021 | 30,110 | $282K |
| 2022 | 33,324 | $282K |
| 2023 | 36,539 | $271K |
| 2024 | 24,905 | $192K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 5,610 | 5,354 | $117K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 5,612 | 5,356 | $117K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 6,692 | 6,267 | $102K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 2,611 | 2,285 | $99K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 5,301 | 5,063 | $99K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 4,328 | 4,052 | $85K |
| 84443 | Thyroid stimulating hormone (TSH) | 9,450 | 8,535 | $80K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 4,235 | 2,865 | $74K |
| 80053 | Comprehensive metabolic panel | 13,057 | 11,600 | $74K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 15,284 | 12,959 | $64K |
| 80061 | Lipid panel | 8,300 | 7,511 | $61K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 3,891 | 3,474 | $52K |
| 87653 | 2,403 | 2,233 | $46K | |
| 36415 | Collection of venous blood by venipuncture | 21,959 | 18,028 | $43K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 1,902 | 1,661 | $25K |
| 84439 | 4,988 | 4,444 | $25K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 4,429 | 4,026 | $20K |
| 83036 | Hemoglobin; glycosylated (A1C) | 4,221 | 3,803 | $20K |
| 80048 | Basic metabolic panel (calcium, ionized) | 3,336 | 2,801 | $16K |
| 82607 | 1,803 | 1,621 | $13K | |
| 86803 | 1,658 | 1,465 | $13K | |
| 80050 | General health panel | 986 | 914 | $13K |
| 82728 | 1,705 | 1,546 | $12K | |
| 87077 | 2,381 | 2,021 | $11K | |
| 87186 | 2,187 | 1,778 | $10K | |
| 87081 | 2,520 | 2,322 | $10K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 235 | 226 | $9K |
| 82746 | 1,392 | 1,243 | $9K | |
| 87522 | Neg quan hep c or qual rna | 407 | 339 | $9K |
| 88342 | 204 | 153 | $8K | |
| 83550 | 1,707 | 1,529 | $7K | |
| 80074 | 384 | 317 | $7K | |
| 85651 | 3,240 | 2,859 | $7K | |
| 87070 | 1,413 | 1,261 | $7K | |
| 83735 | 1,904 | 1,658 | $7K | |
| 86140 | 2,527 | 2,215 | $6K | |
| 83970 | 328 | 295 | $6K | |
| 83540 | 1,921 | 1,730 | $6K | |
| 85027 | 1,731 | 1,505 | $6K | |
| 82248 | 1,726 | 1,399 | $5K | |
| 86038 | 623 | 518 | $4K | |
| 85610 | 1,325 | 865 | $3K | |
| 84403 | 221 | 186 | $3K | |
| 84153 | 325 | 300 | $3K | |
| 86003 | 92 | 41 | $3K | |
| 82043 | 973 | 880 | $3K | |
| 81001 | 1,665 | 1,489 | $3K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 217 | 209 | $3K |
| 87205 | 1,131 | 976 | $3K | |
| 80348 | 325 | 276 | $3K | |
| 87340 | 489 | 410 | $3K | |
| 83516 | 289 | 149 | $2K | |
| 87902 | 12 | 12 | $2K | |
| 82570 | 622 | 514 | $2K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 22 | 22 | $2K |
| 86160 | 275 | 107 | $2K | |
| 80076 | 280 | 252 | $1K | |
| 84702 | 155 | 104 | $1K | |
| 86592 | 540 | 448 | $1K | |
| 84156 | 634 | 517 | $1K | |
| 82784 | 186 | 115 | $1K | |
| 87147 | 293 | 254 | $822.99 | |
| 86430 | 257 | 220 | $783.38 | |
| 80081 | 16 | 12 | $648.51 | |
| 84550 | 294 | 264 | $645.68 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 14 | 12 | $397.41 |
| 86376 | 40 | 37 | $293.77 | |
| 82785 | 28 | 26 | $272.14 | |
| 84144 | 23 | 12 | $270.90 | |
| 86850 | 56 | 48 | $261.87 | |
| 86762 | 35 | 32 | $228.85 | |
| 84460 | 113 | 85 | $220.45 | |
| 84402 | 12 | 12 | $206.87 | |
| 86706 | 27 | 26 | $198.96 | |
| 84270 | 14 | 13 | $166.49 | |
| 87075 | 28 | 26 | $150.76 | |
| 84450 | 78 | 58 | $149.69 | |
| 84436 | 24 | 24 | $101.76 | |
| 86200 | 14 | 13 | $98.93 | |
| 84520 | 62 | 42 | $92.66 | |
| 86900 | 56 | 47 | $79.14 | |
| 86901 | 56 | 47 | $78.52 | |
| 83690 | 16 | 12 | $49.69 | |
| 82565 | 19 | 13 | $36.54 | |
| 84100 | 17 | 12 | $33.46 | |
| 83090 | 12 | 12 | $28.12 | |
| 81003 | 12 | 12 | $16.58 |